Demant A/S
CSE:DEMANT

Watchlist Manager
Demant A/S Logo
Demant A/S
CSE:DEMANT
Watchlist
Price: 212.6 DKK -0.09% Market Closed
Market Cap: 45.5B DKK

DEMANT's latest stock split occurred on May 25, 2016

The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.

Before the split, DEMANT traded at 698 per share. Afterward, the share price was about 142.3.

The adjusted shares began trading on May 25, 2016. This was DEMANT's 3rd stock split, following the previous one in May 8, 2000.

Last Splits:
May 25, 2016
5-for-1
May 8, 2000
5-for-1
Jun 3, 1997
4-for-1
Pre-Split Price
139.6 698
Post-Split Price
142.3
Before
After
Last Splits:
May 25, 2016
5-for-1
May 8, 2000
5-for-1
Jun 3, 1997
4-for-1

Demant A/S
Stock Splits History

DEMANT Stock Splits Timeline
May 25, 2016
May 25, 2016
Split 5-for-1
x5
Pre-Split Price
139.6 698
Post-Split Price
142.3
Before
After
May 8, 2000
May 8, 2000
Split 5-for-1
x5
Pre-Split Price
N/A
Post-Split Price
103.3
Before
After
Jun 3, 1997
Jun 3, 1997
Split 4-for-1
x4
Pre-Split Price
N/A
Post-Split Price
103.3
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
45.96 45.96 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
59.68 59.68 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
51.1285 51.1285 USD N/A
Load More

Demant A/S
Glance View

Demant A/S, an eminent player in the world of hearing healthcare, finds its roots in Denmark, where it was founded in 1904. The journey, sparked by the compassion of founder Hans Demant who sought ways to improve his wife's hearing experience, has evolved into a global operation focused on improving quality of life through innovative hearing solutions. Demant transcends beyond traditional hearing aids, carving a niche in providing a broad range of hearing healthcare services. These include audiometric equipment, hearing implants, diagnostic instruments, and personal communication applications, all aligned with the mission to help people overcome communication barriers. Key to Demant's strategy is its strong emphasis on research and development, ensuring that it remains at the forefront of technological advancements in audiology. The company monetizes its operations through a combination of cutting-edge product sales and a suite of ancillary services that cater to different segments of the hearing healthcare market. Leveraging a robust distribution network, Demant ensures a wide market reach, with offerings meticulously tailored to meet regional consumer needs. Collaborations with retailers, hospitals, and clinics across the globe amplify its market penetration, driving both revenue and brand loyalty. Additionally, Demant taps into the growing demand for auditory digital health solutions, offering cloud-based services that integrate seamlessly into consumer lifestyles. This multifaceted approach not only diversifies revenue streams but also fortifies Demant's standing as a holistic hearing solutions provider, underpinned by a commitment to enhancing living through auditory wellness.

DEMANT Intrinsic Value
341.05 DKK
Undervaluation 38%
Intrinsic Value
Price
Back to Top